Literature DB >> 21358010

HLA-DRBeta1, circulating Th1/Th2 cytokines and immunological homunculus in coronary atherosclerosis.

Amrollah Mostafazadeh1, Mehrdad Saravi, Haleh Akhavan Niaki, Jos Drabbels, Haji Mohammad Gholipour, Milad Minagar, Ezatola Mosavi, Farzad Jalali, Ali Bijani.   

Abstract

Coronary atherosclerotic disease is one of the most endangering health disorder worldwide. This study was designed to investigate the correlation between HLA-DR1 alleles and circulating Th1/Th2 type cytokines in coronary atherosclerosis. By Elisa, Th1/Th2 type cytokines were determined in serum samples of 31 subjects with unstable angina, 27 subjects with chronic stable angina and 24 individuals as normal control. By SSP-PCR, more than 100 alleles of HLA-DRBeta1 were typed in 24 subjects who had skewed serum levels of Th1/Th2 type cytokines. Lipid profiles were determined by the routine methods of clinical laboratory in all subjects. The mean serum concentration of IL-10 in normal control subjects was higher in comparison to the patient groups.0.33±0.59 pg/ml versus 0.064±0.3 pg/ml in unstable angina pectoris group (p<0.028) and 0.22±0.6 pg/ml in chronic stable subjects. There was no statistically significant difference among the groups in serum levels of other desired cytokines (IFN-Gamma, IL-4). 33.33% of normal control subjects were HLA-DR16 positive whereas none of the subjects with chronic stable angina or individuals with unstable angina pectoris was positive for this antigen. The mean concentration of serum LDL-cholesterol in normal control group was high 142.046±35.40 (pg/ml).This preliminary study shows that the atherogenic effect of the LDL- cholesterol may be dampened by HDL-cholesterol through anti inflammatory cytokine IL-10 and HLA-DR16, a phenomenon interpretable via immunological homunculus theory.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358010     DOI: 010.01/ijaai.1119

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  2 in total

1.  MiR-31 promotes Th22 differentiation through targeting Bach2 in coronary heart disease.

Authors:  Rimao Huang; Xuliang Chen; Yadong Long; Ri Chen
Journal:  Biosci Rep       Date:  2019-09-20       Impact factor: 3.840

2.  Interleukin 10, lipid profile, vitamin D, selenium, metabolic syndrome, and serum antioxidant capacity in elderly people with and without cardiovascular disease: Amirkola health and ageing project cohort-based study.

Authors:  Hamid Reza Nematollahi; Reza Hosseini; Ali Bijani; Haleh Akhavan-Niaki; Hadi Parsian; Mahdi Pouramir; Mehrdad Saravi; Mojgan Bagherzadeh; Abbas Mosapour; Massud Saleh-Moghaddam; Majid Rajabian; Monireh Golpour; Amrollah Mostafazadeh
Journal:  ARYA Atheroscler       Date:  2019-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.